UncategorizedHate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says fwadmin / January 22, 2025 Compared to Lilly’s Zepbound (tirzepatide), the once-daily experimental drug would be simpler to produce.
UncategorizedFive takeaways on Trump’s opening trade salvo fwadmin / January 22, 2025 President vows to correct ‘unfair practices’ as US trading partners prepare for an era of tariffs
UncategorizedTrump threatens to double tax rates for foreign nationals and companies fwadmin / January 22, 2025 President orders officials to draw up retaliatory measures against ‘extraterritorial’ taxes
Uncategorized‘Will President Trump even notice Europe?’ asks Zelenskyy fwadmin / January 22, 2025 Ukraine’s president delivers scathing critique in Davos of continent’s reluctance to spend more on defence
UncategorizedUS and India discuss concerns about ‘irregular immigration,’ State Department says fwadmin / January 22, 2025
UncategorizedAsia Tech 2025: Bernstein sees room for recovery amid valuation adjustments fwadmin / January 22, 2025
UncategorizedAuto & Transport Roundup: Market Talk fwadmin / January 22, 2025 Read about North American auto production, Fraport, DHL Group and more in the latest Market Talks covering the Auto and Transport sector.
UncategorizedBasic Materials Roundup: Market Talk fwadmin / January 22, 2025 Find insight on commodities prices, Press Metal Aluminium, BHP, Antofagasta and more in the latest Market Talks covering Basic Materials.